We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medica Group Plc | LSE:MGP | London | Ordinary Share | GB00BYV24996 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 211.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/3/2021 17:46 | Helpful that the share price has run up nicely in the last few weeks given the placing to finance the acquisition! | adamb1978 | |
22/3/2021 17:45 | Yes, a decent trading update as a bonus. It's great to see that they are finding more uses for the technology. There must be a tonne of inorganic growth opportunities out there. | leopoldalcox | |
22/3/2021 17:39 | Sounds like a positive acquisition to enter the US market. Particularly like that all Directors participating in the placing to the tune of £556k incl new NED Junaid Baiwa. Pleasing too that the trading update shows month-on-month growth in 2021 for both Nighthawk and Elective, with discussions already underway for tackling the significant backlog. A strong H2 expected. | mighunter | |
22/3/2021 13:38 | New Proactive research report on Medica, in news section of the Medica Investor Relations site but hadn't seen elsewhere. Central TP up to 189p with upside of 218.5p depending on multiple expansion. Full research report and video here: HTtps://www.google.c | mighunter | |
19/3/2021 23:01 | Some good momentum here, was up much higher earlier in the day. Some motivated buying and lack of stock. | boonkoh | |
19/3/2021 07:29 | Looks like a decent value-add NED appointment this morning - not something I say that often! | 18bt | |
15/3/2021 21:05 | Don't disagree with any of that, jack. I've just had to reassess my view of the company and am now much more cautious. I now see much more as needing growth, rather than being in a profitable technological niche. If there is some good news and a share price spike I may well top slice to reduce my book cost of 134p. Anyroadup, enough for now GLA. apad | apad | |
15/3/2021 20:39 | APAD, looking at the L2P announcement that seems to be about a slick way for them to gather and maintain all the regulatory documents they need from their doctors. They call it a partnership, but I agree it sounds like L2P just sold them a solution. I think MGP have over 400 doctors so presumably that's a lot of qualification certificates, appraisals and insurance documents etc to gather, maintain and refresh! Doctors don't like that sort of paperwork so if it is slick it may help with the recruitment and retention of doctors? The Sectra investment looks to be more substantial and sounds like a good move (switching from an old system to a new one, access to new AI tools etc), but just how much impact it will have is an unknown. They also have not said if it costs more or less than the current system. Interesting to watch this one now after the ride since IPO. I am hopeful that the new management team are making the right moves. Jack. | jumpingjack2016 | |
14/3/2021 18:03 | My notes on competition. Medica Group was the UK and Eire’s leading provider of teleradiology services in 2018, with 1.7m diagnostic imaging reports, up 13.7% from 2017. Its revenue performance was even more impressive, rising by 15.6% year-on-year to £38.9m. Medica’s core business strategy involves working in partnership with NHS Trusts (>100 hospitals), clinics, private hospital groups and diagnostic imaging firms. For its urgent care (NightHawk) reporting service, Medica’s average turnaround time was just 25.3 minutes. This is particularly important in an acute environment where an accurate and timely report can significantly improve a patients’ chance of a positive outcome. Additional leading teleradiology specialists in the UK and Eire include Everlight Radiology, 4Ways Healthcare and Telemedicine Clinic (Unilabs). 24-Hour Teleradiology Reporting in the UK | Everlight Radiologywww.everlig Everlight Radiology United Kingdom. A lifeline for vital radiology services. As radiology becomes an increasingly diverse and challenging discipline, the need for ... TMC - Teleradiology Reporting and Radiology Systems Providerwww.telemedi ... most experienced and technically developed teleradiology groups in the market. ... One in every two people in the UK will be told they have cancer in their life time ... “TMC made the setup of a teleradiology MRI reporting service a thankfully ... 4ways Healthcare - Leading UK Teleradiology Provider4waysdiagnos 4ways is a clinically led UK based teleradiology reporting house, offering open flexible reporting support for NHS Trusts and private companies. Teleradiology Reporting Services - NHS SBSwww.sbs.nhs.uk › fas-teleradiology-re The Teleradiology Reporting Services Framework supports radiology reporting services to meet ... All NHS and wider Public Sector Organisations across the UK. Europe's 10 fastest-growing teleradiology companies ...www.healthcarebus 28 Nov 2019 — The infographic below shows the fastest-growing teleradiology groups we have identified in the UK, Finland, Spain, Hungary, Germany and ... Medica: Teleradiology services to NHS and healthcare ...medica.co.uk Teleradiology market leader in the UK, connecting and supporting clinical professionals to ensure the best possible patient care. Teleradiology in the UK: friend or foe? A radiologist's ...www.ncbi.nlm.nih. by E Pakdemirli · 2019 · Cited by 1 — The vast majority of UK radiologists who do home reporting have substantial posts in the National Health Service (NHS). Remote reporting ( ... Specialized Teleradiology Services for UK - Outsource2indiawww.o The lack of trained staff with expertise in radiology has moved more healthcare centers and hospitals in the UK to opt for teleradiology services. Today, you can ... UK call for regulation of overseas teleradiology - DI Europewww.dieurope.c All doctors practising in the UK including those working for teleradiology companies must be registered and hold a current licence to practise with the General ... Radiology Reporting - DMC Healthcaredmchealthc UK-based radiologists using the best reporting tech available, supported by a ... We have been operating since 2012, meeting the demand for high quality, accurate reporting services across the UK. ... Routine Tele-Radiology reporting ... apad | apad | |
14/3/2021 13:50 | I've been impressed with Stuart Quin in the couple of presentations i've viewed. What I don't understand yet is how the competition are able to operate successfully if they don't have the unique links into the NHS patient records and still able to apply pressure to MGP's margins. Bearing in mind the service MGP supply is generally an overflow product along with out of hours it seems the NHS backlog is going to provide really strong volumes post covid as the NHS looks to catch up. The only blackmark is the steady but shallow decline in gross margins. In an ideal world I'd prefer strong revenue growth with margins improving :-). | cockerhoop | |
14/3/2021 12:32 | My understanding is that in the UK Medica has the advantage over their competitors of their systems being linked directly into the NHS. Whilst the Australian verture is indeed a joint venture with an incumbent the Irish acq was a takeover.The new PACS system looks an attempt to improve margin by streamlining their systems which reading the Liberum note currently sounds rather clunky to route scan requests. | cockerhoop | |
14/3/2021 11:28 | Medica launches partnership with L2P 2021 Medica procures Sectra PACS 2021 The first of these is medical reporting software, the second is image analysis and support (they are changing their existing partner to Sectra in 2022). Their enterprises abroad tend to be in partnership with an incumbent. I'm beginning to wonder what there is at the heart of Medica that makes it special? Can anybody help? apad | apad | |
26/2/2021 10:50 | Advancing nicely - presumably not much stock around given the ease of progress. Cheers for posting that extract Rob, saved me doing the same :o)) | rivaldo | |
26/2/2021 00:47 | Liberum initiates coverage on Medica at 'buy'Iain Gilbert25 Feb, 2021 13:37 25 Feb, 2021 13:37medicalAnalysts at Liberum initiated coverage on teleradiology firm Medica on Thursday at 'buy', pointing to faster earnings per share growth, higher earnings quality and underestimated optionality.Liberum said Medica's new management team had made "the right investments" to take advantage of surging end-market demand and "incredibly tight supply", a move that the analysts believe will allow it to deliver a 20% organic EPS compound annual growth rate to 2025.Furthermore, Liberum expects Medica to use its strong balance sheet for EPS accretive mergers and acquisitions that will diversify the business into new services and geographies.Liberum also acknowledged Medica's addition of new chief executive and chief financial officers over the last two years, highlighting the team's "ambitious plans" to optimise growth in the firm's core markets through recent investments that were now bearing fruit."We believe that Medica is set to deliver some of the fastest EPS growth in the UK healthcare services sector whilst M&A provides significant optionality. Yet it trades at a c.45% discount to peers," said Liberum."We expect this valuation gap to close over the next 12-18 months with earnings delivery and further M&A. We, therefore, initiate with a BUY rating and a £2.00 TP, implying 71% upside. Medica is now our top pick in UK SMID." | rob the slob | |
25/2/2021 16:15 | Hopefully Liberum drums up more interest in Medica. Would be good to have steady trading volumes, small spreads! | boonkoh | |
25/2/2021 09:28 | Liberum have this morning initiated coverage on MGP with a huge 66 page report, saying Buy with a 200p target..... | rivaldo | |
22/2/2021 14:16 | Agreed - looks a very sensible development with long term benefits. | 18bt | |
22/2/2021 13:30 | Surprised by the muted reaction today. This is a big growth opportunity, into AU and NZ.Looks like the investment required is modest, given they didn't disclose any figures.And maybe at some point the Aussie company might make a bid and take over Medica. They have a market cap many times higher. | boonkoh | |
16/2/2021 11:15 | Interesting article which gives a good sense of the direction of travel. The question is timing I suppose. | jumpingjack2016 | |
15/2/2021 11:59 | Travel shares being run up today on vaccination news, but what will recover first is medical diagnostic tests and Elective surgeries, as hospitals rapidly empty of Covid patients. | boonkoh | |
15/2/2021 09:06 | Medium term this could be a tailwind? | cockerhoop | |
05/2/2021 14:27 | Really clear pathway to an outstanding year to come.Vaccination rates going well.Hospital admissions dropping steadily now.Numerous media articles about backlog of elective surgeries and treatments.Everyone' | boonkoh |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions